H
GSK icon

HoyleCohen’s GSK GSK Stock Holding History

HoyleCohen’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-4,853
Closed -$264K – 259
2022
Q2 		$264K Hold
4,853
– – 0.03% 222
2022
Q1 		$264K Buy
4,853
+1
+0% +$54 0.02% 234
2021
Q4 		$267K Buy
+4,852
New +$252K 0.02% 244
2021
Q2 		– Sell
-5,589
Closed -$249K – 270
2021
Q1 		$249K Sell
5,589
-100
-2% -$4.54K 0.03% 236
2020
Q4 		$262K Buy
+5,689
New +$261K 0.03% 202
2020
Q1 		– Sell
-4,121
Closed -$242K – 181
2019
Q4 		$242K Sell
4,121
-163
-4% -$9.07K 0.04% 181
2019
Q3 		$229K Hold
4,284
– – 0.04% 181
2019
Q2 		$214K Hold
4,284
– – 0.04% 179
2019
Q1 		$224K Buy
+4,284
New +$214K 0.04% 170

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

HoyleCohen's GSK Position: Q3 2022 in Review

HoyleCohen sold out of GSK (GSK) in Q3 2022, closing a stake of 4,853 shares — an estimated $264K sold.

HoyleCohen first reported a position in GSK in Q1 2019 and held it in 9 quarters. The position peaked at $267K in Q4 2021. 742 funds tracked by Wall St. Rank hold GSK as of Q3 2022.

  • HoyleCohen reported no remaining GSK position as of Q3 2022 after selling out during the quarter.
  • HoyleCohen sold 4,853 GSK shares in Q3 2022, an estimated $264K.
  • HoyleCohen first reported a position in GSK in Q1 2019 and held it in 9 quarters.
  • HoyleCohen's GSK position peaked at $267K in Q4 2021.
  • 742 funds tracked by Wall St. Rank held GSK as of Q3 2022.

Based on HoyleCohen's 13F filing for Q3 2022, filed 2 Nov 2022.